Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Damora Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 24.55 · gapped above the open, then crossed back over prior close. High/low 26.94 at 9:45 am ET, 24.55 at 4:00 pm ET.
104 institutional managers report a position in Damora Therapeutics, Inc. worth $1.7B between them, filed on form 13F for the quarter ending 2026-06-30. 18 of them hold 80% of it, the largest being FMR LLC at 14.35%.
79 more managers in the register
18 managers hold 80% of the $1.7B institutional base. The other 86 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 77 days old and does not move with the price above it.
DMRA (Damora Therapeutics, Inc.) has 3 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
via Fairmount Funds Management LLC, VR Adviser, LLC, RA Capital Management, LLC +7 more · 13.54% of DMRA, 6.24% of JBIO
via VR Adviser, LLC, Fairmount Funds Management LLC, Bellevue Group AG +10 more · 5.60% of DMRA, 5.57% of ORKA
via Fairmount Funds Management LLC, VR Adviser, LLC, Fcpm III Services B.V. +5 more · 13.54% of DMRA, 9.44% of CBIO
via VR Adviser, LLC, Jupiter Topco LLC, Commodore Capital LP +6 more · 5.60% of DMRA, 4.03% of RACC
via venBio Select Advisor LLC, Fairmount Funds Management LLC, RA Capital Management, LLC +5 more · 5.88% of DMRA, 10.26% of FTH
via venBio Select Advisor LLC, RA Capital Management, LLC, Jupiter Topco LLC +3 more · 5.88% of DMRA, 7.55% of ASND
Managers holding a meaningful stake in DMRA also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.